BNP Paribas’s Zimmer Biomet ZBH Stock Holding History

BNP Paribas’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$2.83K	–	380
2025 Q1	$2.83K	Hold	25	–	–	﹤0.01%	339
2024 Q4	$2.64K	Buy	+25	New	+$2.68K	﹤0.01%	359

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BNP Paribas's ZBH Position: Q2 2025 in Review

BNP Paribas sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 25 shares — an estimated $2.83K sold.

BNP Paribas first reported a position in ZBH in Q4 2024 and held it in 2 quarters. The position peaked at $2.83K in Q1 2025. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

BNP Paribas reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
BNP Paribas sold 25 Zimmer Biomet shares in Q2 2025, an estimated $2.83K.
BNP Paribas first reported a position in Zimmer Biomet in Q4 2024 and held it in 2 quarters.
BNP Paribas's Zimmer Biomet position peaked at $2.83K in Q1 2025.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on BNP Paribas's 13F filing for Q2 2025, filed 14 Aug 2025.